In the study of januvia as add-on combination therapy with metformin and rosiglitazone table 1 , through week 54 the adverse reactions reported regardless of investigator assessment of causality in 5 of patients treated with januvia and more commonly than in patients treated with placebo were upper respiratory tract infection januvia, 15.
Continue reading→

If you are suffering from diabetic ketoacidosis you should immediately inform your doctor, as januvia cannot be taken in this case.
Continue reading→

In the 24-week study, 9 of patients receiving januvia 100 mg and 21 of patients receiving placebo required rescue therapy.
Continue reading→